{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:55:56Z","timestamp":1791320156529,"version":"4.3.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-022-00917-7","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T05:04:49Z","timestamp":1662008689000},"page":"1141-1152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["USP3 deubiquitinates and stabilizes the adapter protein ASC to regulate inflammasome activation"],"prefix":"10.1038","volume":"19","author":[{"given":"Wanxin","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9579-1711","authenticated-orcid":false,"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8121-4718","authenticated-orcid":false,"given":"Chunhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8440-2274","authenticated-orcid":false,"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9365-4497","authenticated-orcid":false,"given":"Chengjiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"key":"917_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016;16:407\u201320.","journal-title":"Nat Rev Immunol"},{"key":"917_CR2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19:477\u201389.","journal-title":"Nat Rev Immunol"},{"key":"917_CR3","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140:821\u201332.","journal-title":"Cell."},{"key":"917_CR4","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm.3893","volume":"21","author":"H Guo","year":"2015","unstructured":"Guo H, Callaway JB, Ting JP. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015;21:677\u201387.","journal-title":"Nat Med"},{"key":"917_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.coi.2020.10.011","volume":"68","author":"MT Milner","year":"2021","unstructured":"Milner MT, Maddugoda M, Gotz J, Burgener SS, Schroder K. The NLRP3 inflammasome triggers sterile neuroinflammation and Alzheimer\u2019s disease. Curr Opin Immunol. 2021;68:116\u201324.","journal-title":"Curr Opin Immunol"},{"key":"917_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1146\/annurev-immunol-031210-101405","volume":"29","author":"BK Davis","year":"2011","unstructured":"Davis BK, Wen H, Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol. 2011;29:707\u201335.","journal-title":"Annu Rev Immunol"},{"key":"917_CR7","doi-asserted-by":"publisher","first-page":"118918","DOI":"10.1016\/j.lfs.2020.118918","volume":"267","author":"Q Ge","year":"2021","unstructured":"Ge Q, Chen X, Zhao Y, Mu H, Zhang J. Modulatory mechanisms of NLRP3: Potential roles in inflammasome activation. Life Sci. 2021;267:118918.","journal-title":"Life Sci"},{"key":"917_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/febs.15118","volume":"287","author":"G Lopez-Castejon","year":"2020","unstructured":"Lopez-Castejon G. Control of the inflammasome by the ubiquitin system. Febs j. 2020;287:11\u201326.","journal-title":"Febs j"},{"key":"917_CR9","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3389\/fimmu.2018.01054","volume":"9","author":"DW Shim","year":"2018","unstructured":"Shim DW, Lee KH. Posttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome. Front Immunol. 2018;9:1054.","journal-title":"Front Immunol"},{"key":"917_CR10","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2014","unstructured":"Popovic D, Vucic D, Dikic I. Ubiquitination in disease pathogenesis and treatment. Nat Med. 2014;20:1242\u201353.","journal-title":"Nat Med"},{"key":"917_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03669-z","volume":"9","author":"F Humphries","year":"2018","unstructured":"Humphries F, Bergin R, Jackson R, Delagic N, Wang B, Yang S, et al. The E3 ubiquitin ligase Pellino2 mediates priming of the NLRP3 inflammasome. Nat Commun. 2018;9:1560.","journal-title":"Nat Commun"},{"key":"917_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13727","volume":"7","author":"H Song","year":"2016","unstructured":"Song H, Liu B, Huai W, Yu Z, Wang W, Zhao J, et al. The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3. Nat Commun. 2016;7:13727.","journal-title":"Nat Commun"},{"key":"917_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.molcel.2012.11.009","volume":"49","author":"BF Py","year":"2013","unstructured":"Py BF, Kim MS, Vakifahmetoglu-Norberg H, Yuan J. Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol Cell. 2013;49:331\u20138.","journal-title":"Mol Cell"},{"key":"917_CR14","doi-asserted-by":"crossref","unstructured":"Palazon-Riquelme P, Worboys JD, Green J, Valera A, Martin-Sanchez F, Pellegrini C, et al. USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation. EMBO Rep. 2018;19:e44766.","DOI":"10.15252\/embr.201744766"},{"key":"917_CR15","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00018-016-2396-6","volume":"74","author":"F Hoss","year":"2017","unstructured":"Hoss F, Rodriguez-Alcazar JF, Latz E. Assembly and regulation of ASC specks. Cell Mol Life Sci. 2017;74:1211\u201329.","journal-title":"Cell Mol Life Sci"},{"key":"917_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11929","volume":"7","author":"MS Dick","year":"2016","unstructured":"Dick MS, Sborgi L, Ruhl S, Hiller S, Broz P. ASC filament formation serves as a signal amplification mechanism for inflammasomes. Nat Commun. 2016;7:11929.","journal-title":"Nat Commun"},{"key":"917_CR17","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1084\/jem.20132486","volume":"211","author":"MA Rodgers","year":"2014","unstructured":"Rodgers MA, Bowman JW, Fujita H, Orazio N, Shi M, Liang Q, et al. The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation. J Exp Med. 2014;211:1333\u201347.","journal-title":"J Exp Med"},{"key":"917_CR18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/ni.2215","volume":"13","author":"CS Shi","year":"2012","unstructured":"Shi CS, Shenderov K, Huang NN, Kabat J, Abu-Asab M, Fitzgerald KA, et al. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol. 2012;13:255\u201363.","journal-title":"Nat Immunol"},{"key":"917_CR19","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.4049\/jimmunol.1402851","volume":"194","author":"K Guan","year":"2015","unstructured":"Guan K, Wei C, Zheng Z, Song T, Wu F, Zhang Y, et al. MAVS Promotes Inflammasome Activation by Targeting ASC for K63-Linked Ubiquitination via the E3 Ligase TRAF3. J Immunol. 2015;194:4880\u201390.","journal-title":"J Immunol"},{"key":"917_CR20","doi-asserted-by":"publisher","first-page":"8865","DOI":"10.1096\/fj.201802418R","volume":"33","author":"KL Siu","year":"2019","unstructured":"Siu KL, Yuen KS, Casta\u00f1o-Rodriguez C, Ye ZW, Yeung ML, Fung SY, et al. Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. Faseb j. 2019;33:8865\u201377.","journal-title":"Faseb j"},{"key":"917_CR21","doi-asserted-by":"publisher","first-page":"109904","DOI":"10.1016\/j.celrep.2021.109904","volume":"37","author":"L Zhang","year":"2021","unstructured":"Zhang L, Ko CJ, Li Y, Jie Z, Zhu L, Zhou X, et al. Peli1 facilitates NLRP3 inflammasome activation by mediating ASC ubiquitination. Cell Rep. 2021;37:109904.","journal-title":"Cell Rep"},{"key":"917_CR22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/1873-3468.12558","volume":"591","author":"JY Lee","year":"2017","unstructured":"Lee JY, Seo D, You J, Chung S, Park JS, Lee JH, et al. The deubiquitinating enzyme, ubiquitin-specific peptidase 50, regulates inflammasome activation by targeting the ASC adaptor protein. FEBS Lett. 2017;591:479\u201390.","journal-title":"FEBS Lett"},{"key":"917_CR23","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1073\/pnas.1719856115","volume":"115","author":"YC Cheng","year":"2018","unstructured":"Cheng YC, Shieh SY. Deubiquitinating enzyme USP3 controls CHK1 chromatin association and activation. Proc Natl Acad Sci USA. 2018;115:5546\u201351.","journal-title":"Proc Natl Acad Sci USA"},{"key":"917_CR24","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1007\/s00018-016-2255-5","volume":"73","author":"GL Grice","year":"2016","unstructured":"Grice GL, Nathan JA. The recognition of ubiquitinated proteins by the proteasome. Cell Mol Life Sci. 2016;73:3497\u2013506.","journal-title":"Cell Mol Life Sci"},{"key":"917_CR25","doi-asserted-by":"crossref","unstructured":"Cai X, Xu H, Chen ZJ. Prion-Like Polymerization in Immunity and Inflammation. Cold Spring Harb Perspect Biol. 2017;9:a023580.","DOI":"10.1101\/cshperspect.a023580"},{"key":"917_CR26","doi-asserted-by":"publisher","first-page":"7147","DOI":"10.4049\/jimmunol.180.11.7147","volume":"180","author":"P Pelegrin","year":"2008","unstructured":"Pelegrin P, Barroso-Gutierrez C, Surprenant A. P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophage. J Immunol. 2008;180:7147\u201357.","journal-title":"J Immunol"},{"key":"917_CR27","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/nature06939","volume":"453","author":"SC Eisenbarth","year":"2008","unstructured":"Eisenbarth SC, Colegio OR, O\u2019Connor W, Sutterwala FS, Flavell RA. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature. 2008;453:1122\u20136.","journal-title":"Nature."},{"key":"917_CR28","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1016\/j.vaccine.2007.03.045","volume":"25","author":"A Sokolovska","year":"2007","unstructured":"Sokolovska A, Hem SL, HogenEsch H. Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants. Vaccine. 2007;25:4575\u201385.","journal-title":"Vaccine."},{"key":"917_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.immuni.2011.02.006","volume":"34","author":"G Guarda","year":"2011","unstructured":"Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, Forster I, et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity. 2011;34:213\u201323.","journal-title":"Immunity."},{"key":"917_CR30","doi-asserted-by":"publisher","first-page":"6301","DOI":"10.1172\/JCI138234","volume":"130","author":"Y Guo","year":"2020","unstructured":"Guo Y, Li L, Xu T, Guo X, Wang C, Li Y, et al. HUWE1 mediates inflammasome activation and promotes host defense against bacterial infection. J Clin Investig. 2020;130:6301\u201316.","journal-title":"J Clin Investig"},{"key":"917_CR31","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.it.2019.09.005","volume":"40","author":"Y Xue","year":"2019","unstructured":"Xue Y, Enosi Tuipulotu D, Tan WH, Kay C, Man SM. Emerging Activators and Regulators of Inflammasomes and Pyroptosis. Trends Immunol. 2019;40:1035\u201352.","journal-title":"Trends Immunol"},{"key":"917_CR32","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/cr.2013.170","volume":"24","author":"J Cui","year":"2014","unstructured":"Cui J, Song Y, Li Y, Zhu Q, Tan P, Qin Y, et al. USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors. Cell Res. 2014;24:400\u201316.","journal-title":"Cell Res"},{"key":"917_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bbrc.2017.08.036","volume":"492","author":"S Fu","year":"2017","unstructured":"Fu S, Shao S, Wang L, Liu H, Hou H, Wang Y, et al. USP3 stabilizes p53 protein through its deubiquitinase activity. Biochem Biophys Res Commun. 2017;492:178\u201383.","journal-title":"Biochem Biophys Res Commun"},{"key":"917_CR34","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.cub.2007.10.034","volume":"17","author":"F Nicassio","year":"2007","unstructured":"Nicassio F, Corrado N, Vissers JH, Areces LB, Bergink S, Marteijn JA, et al. Human USP3 is a chromatin modifier required for S phase progression and genome stability. Curr Biol. 2007;17:1972\u20137.","journal-title":"Curr Biol"},{"key":"917_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08934-x","volume":"21","author":"K Shi","year":"2021","unstructured":"Shi K, Zhang JZ, Yang L, Li NN, Yue Y, Du XH, et al. Protein deubiquitylase USP3 stabilizes Aurora A to promote proliferation and metastasis of esophageal squamous cell carcinoma. BMC Cancer. 2021;21:1196.","journal-title":"BMC Cancer"},{"key":"917_CR36","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/ni.3641","volume":"18","author":"B Liu","year":"2017","unstructured":"Liu B, Zhang M, Chu H, Zhang H, Wu H, Song G, et al. The ubiquitin E3 ligase TRIM31 promotes aggregation and activation of the signaling adaptor MAVS through Lys63-linked polyubiquitination. Nat Immunol. 2017;18:214\u201324.","journal-title":"Nat Immunol"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00917-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00917-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00917-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T07:18:00Z","timestamp":1663917480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00917-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["917"],"URL":"https:\/\/doi.org\/10.1038\/s41423-022-00917-7","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]},"assertion":[{"value":"4 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}